Jan David

Jan David

Auto-generated profile, based on publicly available information

Jan David

Department of Children and Adolescents, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2020 in Klinische Padiatrie
Verified
Journal Article
Closed access
PDF file
JDJan David
Jan David
MSMichaela Sibikova
Michaela Sibikova
SAShenali Anne Amaratunga
Shenali Anne Amaratunga
JLJan Lebl
Jan Lebl
Since December 2019, the SARS-CoV-2 virus, a beta coronavirus which can cause the coronavirus disease 2019 (COVID-19) has been spreading around the world. SARS-CoV-2 is highly infectious, thereby the entire population is generally susceptible. This virus spread throughout almost the entire world quite rapidly. At the time of writing this article, COVID-19 has been confirmed in most countries including the Czech Republic (CZ). The main routes of transmission are respiratory droplets and patient-to-patient contact. Compared with the general population, pediatric cases are milder, less prevalent and most of them have been linked epidemiologically to cases in known adults (Hong H et al., Pediatr Neonatol 2020; 61: 131–132; Armann JP et al., Dtsch Arztebl Int 2020; 117: 373–374). On the other hand, pandemic-related measures impacted general pediatric care. This situation has led to reductions in emergency room visits and thereby, a decreased number of referrals for hospitalization (Tartari F et al., J Eur Acad Dermatol Venereol 2020; 10.1111/jdv.1655). Taking this into account, pediatric care providers have had to make adjustments. Some of pediatric units were adapted to accommodate adult patients (Philips K et al., J Pediatr 2020; S0022–3476(20)30564–3). The COVID-19 pandemic has triggered an expansion in telemedicine across the world as well (Berg E et al., J Pediatr Gastroenterol Nutr 2020; 10.1097/MPG.0000000000002749). These factors could lead to a lower number of overall hospital admissions and, similarly, to a change in the spectrum of inpatient diagnoses. In CZ, on the 1st of March, 2020, the first case of COVID-19 was confirmed. During the 75 days that followed, a total of 356,515 individuals were tested, 8,480 had positive COVID-19 polymerase chain reaction tests (Ministry of Health of the Czech Republic 2020). In the pediatric population (≤15 years), 512 (6.2%) patients were detected, fortunately, no deaths were reported (Ministry of Health of the Czech Republic 2020). A lot of government restrictions were performed, e. g. school closures (from the 11th of March, 2020), limited possibilities of travelling due to border closures (from the 16th of March, 2020), and the mandatory wearing of face masks or covering of the nose and mouth in the general population (from the 18th of March, 2020). During this time, we observed a lower number of pediatric patients and a different distribution of diagnoses than per usual. Therefore, the aim of this study was to analyze the number of inpatients/outpatients and spectrum of inpatients before and during the COVID-19 pandemic. Firstly, we performed a multi-center retrospective study based on the anonymous analysis of numbers of inpatients and outpatients from pediatric departments in nine regional Czech hospitals in four consecutive months (January, February, March and April) in the years 2019 and 2020. The number of admissions in all four months was stable in 2019, ranging around 1692 to 1808 per month. In 2020, there is a notable decline in admitted patients with January having the highest number of 1760 patients and April having the lowest number of patients – 842. The same trend was observed in outpatients when comparing data from 2019 and 2020 ([Fig. 1]). Secondly, we analyzed clinical reports from admitted patients at the Department of Pediatrics of the Motol University Hospital in Prague (a tertiary care centre), in order to identify if spectrum of diagnoses of hospitalized patients were different before and during the pandemic. The period of data analysis was reported from March 2019 (reference period) and March 2020 (pandemic period). The total number of admitted patients were 437 and 327 respectively, with a median age of 7.5 years (range 0–19) and 10 years (range 0–19) respectively. Therefore, we were able to compare the spectrum of diagnoses in acute and planned admissions in both monitored periods ([Table 1]). We observed a 25% decline of all inpatients during the period of the pandemic. Interestingly, this is similar to the inpatients – outpatients’ situation in other Czech hospitals ([Fig. 1]). We can speculate that the main reason for the decline in the number of urgent admissions in the CZ is the increased focus on hygiene, social distancing practises, school closures, limited possibilities of travelling due to border closures, and the mandatory wearing of face masks or covering of the nose and mouth in the general population. This can lead to a reduction of the incidence of infective diseases (mainly gastroenteritis and other viral infections), however in the most affected areas, a decline of these diseases in the adult population has not yet been reported (Comelli I et al., Acta Biomed 2020; 91: 45–49). On the other hand, it is possible that, due to the priority and focus on COVID-19, first-line health care providers could have missed, or been delayed in the correct diagnosis and treatment of febrile patients with respiratory or gastrointestinal symptomatology (Harahsheh AS et al., J Pediatr 2020; S0022–3476(20)30556–4). The decline in planned admissions was expected because children with chronic disease present a fragile group, where COVID-19 could be an aggravating factor, especially for patients with bronchial asthma or diabetes mellitus (Abrams EM et al., J Pediatr 2020; S0022–3476(20)30528-X; Ho C et al., J Pediatr 2020: S0022–3476(20)30571–0). The ongoing pandemic could lead to planned admissions being postponed, when possible, either by the side of the parents (due to parent anxiety) or by the initiative of the consulting physician (due COVID-19 precautionary measures, shortage of staff, shortage of beds etc.). However paradoxically, our data showed an increasing trend in the number of planned admissions. Therefore, we can conclude that the main reason for the decline in the number of inpatients is the decrease of acute admissions. In other European countries, similar observations have been reported as well (Dann L et al., Arch Dis Child 2020; archdischild-2020–319654; Roland D et al., Lancet Child Adolesc Health 2020; 4: e32–e33). Parent’s wariness, anxiety and lack of transportation options, pertaining to the COVID-19 pandemic could play a role in the lack of visits to emergency departments as well. This could lead to the late diagnosis of potentially life-threatening conditions. Therefore, it is important to prevent or reduce parents’ and childrens’ worry, fear, and stress which can lead to the excessive “coronaphobia” (Jiao WY et al., J Pediatr 2020; S0022–3476(20)30336-X; Lazzerini M et al., Lancet Child Adolesc Health 2020; 4: e10–e11). However, in our tertiary care centre, we observed only two cases of delayed diagnosis due to the COVID-19 pandemic and related restrictions and patients’ fear (one child with manifestation of diabetes mellitus with severe ketoacidosis and one child with manifestation of Crohn’s disease). We can conclude that the main reason for the decline in the number of inpatients is the decrease of acute admissions. Similarly, we could speculate that government restrictions (mainly social distancing practices and mandatory wearing of facial coverings/masks) could have led to the reduced incidence of infective diseases in the Czech pediatric population. The difference in planned and acute admissions shows that infants and children with chronic diseases are dependent on hospital treatment regardless of a lockdown. Thus, it is important to prevent and reduce parents’ and childrens’ “coronaphobia” and emphasize appropriate and timely care for sick children. Finally, our data may be helpful toward political discussions concerning financial compensations for health care providers. Publication Date: 26 October 2020 (online) © 2020. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

1 October 2022 in Journal of Paediatrics and Child Health
Verified
Journal Article
Closed access
JDJan David
Jan David
OHOndrej Hradsky
Ondrej Hradsky
PJPetr Jabandziev
Petr Jabandziev
EKEva Klaskova
Eva Klaskova
HJHelena Jirincova
Helena Jirincova
JLJan Lebl
Jan Lebl

22 August 2018 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
JDJan David
Jan David
PCPetr Chrastina
Petr Chrastina
HVHana Vinohradska
Hana Vinohradska
ETEva Al Taji
Eva Al Taji
AHAndrea Holubova
Andrea Holubova
FVFelix Votava
Felix Votava

18 July 2024 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
KMKatarina Mitrova
Katarina Mitrova
KCKarin Cerna
Karin Cerna
KZKristyna Zdychyncova
Kristyna Zdychyncova
BPBarbora Pipek
Barbora Pipek
JSJana Svikova
Jana Svikova
DDDana Duricova
Dana Duricova
Evidence on serological responses to vaccination in children exposed to ustekinumab (UST) or vedolizumab (VDZ) in utero is lacking. This multicentre prospective study aimed to assess the impact of prenatal exposure to UST or VDZ due to maternal inflammatory bowel disease (IBD) on serological responses to vaccination and other immunological parameters in exposed children. Children aged ≥ 1 year who were exposed in utero to UST or VDZ and completed at least 1-year of mandatory vaccination were included. We assessed the serological response to vaccination (non-live: tetanus, diphtheria, and Haemophilus influenzae B; live: mumps, rubella, and measles), whole blood count, and immunoglobulin levels. The control group comprised unexposed children born to mothers without IBD. A total of 23 children (median age, 25 months) exposed to UST (n = 13) or VDZ (n = 10) and 10 controls (median age, 37 months) were included. The serological response to vaccination was comparable between the UST and VDZ groups and controls, with an adequate serological response rate of ≥ 80%. Only children exposed to UST showed a slightly reduced serological response to mumps (67% vs. 86% in controls), whereas all children exposed to VDZ showed an adequate response. The majority of the exposed children had normal levels of individual immunoglobulin classes, similar to the controls. No severe pathology was observed in any of the children.Conclusion: Despite the limited sample size, our findings suggest that in utero exposure to VDZ or UST does not significantly impair the vaccine response or broader immunological parameters in exposed children. What is known:• Treatment with anti-TNF inhibitors during pregnancy does not appear to affect serologic response to vaccination in exposed children.• Evidence on the efficacy of vaccination in children exposed to ustekinumab or vedolizumab in utero is almost lacking.What is new:• Our findings suggest that in utero exposure to ustekinumab or vedolizumab does not significantly affect the serological responses to common childhood non-live (tetanus, Haemophilus influenzae B, diphtheria) and live vaccines (measles, mumps, rubella).• No major adverse effects on overall immunological health were observed in children exposed in utero to ustekinumab or vedolizumab.

20 August 2022 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
JDJan David
Jan David
VSVeronika Stara
Veronika Stara
OHOndrej Hradsky
Ondrej Hradsky
JTJana Tuckova
Jana Tuckova
KSKaterina Slaba
Katerina Slaba
JLJan Lebl
Jan Lebl

3 February 2022 in Klinische Padiatrie
Verified
Journal Article
Closed access
PDF file
JDJan David
Jan David
LTLedjona Toni
Ledjona Toni
FFFilip Fencl
Filip Fencl
RHRene Hrdlicka
Rene Hrdlicka
IBIrena Buksakowska
Irena Buksakowska
JLJan Lebl
Jan Lebl
As a direct consequence of the worldwide pandemic of the novel 2019 coronavirus disease (COVID-19, SARS-CoV-2 infection), pediatricians started to encounter a novel multisystem condition resulting from an aberrant immune response to SARS-CoV-2 in children and adolescents in early 2020. Due to partial clinical overlap with Kawasaki disease, it was originally assigned as Kawasaki-like disease, and later specified as a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS), or Multisystem inflammatory syndrome in children (MIS-C). MIS-C is characterized by multi-organ and systemic involvement, with fever and predominantly cardiac, gastrointestinal, skin and mucosal symptoms. Neurological manifestations occur in 15–40% of affected children and adolescents, and may include both the peripheral and central nervous system (Abdel-Mannan O et al., JAMA Neurol 2020; 77: 1–6). Most commonly, these include headaches, meningism, confusion, seizures, unconsciousness, dysarthria, dysphagia, cerebral ataxia, muscle weakness/hyporeflexia, or slow activity on electroencephalography (EEG) (Abdel-Mannan O et al., JAMA Neurol 2020; 77: 1–6). When cerebrospinal fluid is examined, the findings are negative or aseptic (Lad SS et al., Indian J Pediatr 2021; 88: 294–295). We have observed the first documented pediatric patient with posterior reversible encephalopathy syndrome (PRES) as a neurological complication of MIS-C (diagnostic criteria according to World Health Organization definition, https://www.who.int/publications/i/item/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19). Publication Date: 03 February 2022 (online) © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14,70469 Stuttgart, Germany